Recent treatment strategy for advanced squamous cell carcinoma of the lung in Japan

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Squamous cell carcinoma of the lung is associated with smoking in its development and comprises about 20–30% of all lung cancers. Its treatment strategy had been limited for the past decades, inevitably resulting in the poor outcome. However in the 2010s, it has dramatically changed mainly with the recent clinical introduction of immune checkpoint inhibitors. In this review, we will introduce various clinical studies involving squamous cell carcinoma of the lung.

Original languageEnglish
JournalInternational Journal of Clinical Oncology
DOIs
Publication statusPublished - Jan 1 2019

Fingerprint

Squamous Cell Carcinoma
Japan
Lung
Lung Neoplasms
Smoking
Clinical Studies

Keywords

  • Cytotoxic drug
  • Immune checkpoint inhibitor
  • Squamous cell carcinoma of the lung

ASJC Scopus subject areas

  • Surgery
  • Hematology
  • Oncology

Cite this

@article{38e49df0be2f40ddb1e6ff13704369f8,
title = "Recent treatment strategy for advanced squamous cell carcinoma of the lung in Japan",
abstract = "Squamous cell carcinoma of the lung is associated with smoking in its development and comprises about 20–30{\%} of all lung cancers. Its treatment strategy had been limited for the past decades, inevitably resulting in the poor outcome. However in the 2010s, it has dramatically changed mainly with the recent clinical introduction of immune checkpoint inhibitors. In this review, we will introduce various clinical studies involving squamous cell carcinoma of the lung.",
keywords = "Cytotoxic drug, Immune checkpoint inhibitor, Squamous cell carcinoma of the lung",
author = "Satoru Senoo and Kiichiro Ninomiya and Katsuyuki Hotta and Katsuyuki Kiura",
year = "2019",
month = "1",
day = "1",
doi = "10.1007/s10147-019-01424-y",
language = "English",
journal = "International Journal of Clinical Oncology",
issn = "1341-9625",
publisher = "Springer Japan",

}

TY - JOUR

T1 - Recent treatment strategy for advanced squamous cell carcinoma of the lung in Japan

AU - Senoo, Satoru

AU - Ninomiya, Kiichiro

AU - Hotta, Katsuyuki

AU - Kiura, Katsuyuki

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Squamous cell carcinoma of the lung is associated with smoking in its development and comprises about 20–30% of all lung cancers. Its treatment strategy had been limited for the past decades, inevitably resulting in the poor outcome. However in the 2010s, it has dramatically changed mainly with the recent clinical introduction of immune checkpoint inhibitors. In this review, we will introduce various clinical studies involving squamous cell carcinoma of the lung.

AB - Squamous cell carcinoma of the lung is associated with smoking in its development and comprises about 20–30% of all lung cancers. Its treatment strategy had been limited for the past decades, inevitably resulting in the poor outcome. However in the 2010s, it has dramatically changed mainly with the recent clinical introduction of immune checkpoint inhibitors. In this review, we will introduce various clinical studies involving squamous cell carcinoma of the lung.

KW - Cytotoxic drug

KW - Immune checkpoint inhibitor

KW - Squamous cell carcinoma of the lung

UR - http://www.scopus.com/inward/record.url?scp=85062685719&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062685719&partnerID=8YFLogxK

U2 - 10.1007/s10147-019-01424-y

DO - 10.1007/s10147-019-01424-y

M3 - Review article

C2 - 30847617

AN - SCOPUS:85062685719

JO - International Journal of Clinical Oncology

JF - International Journal of Clinical Oncology

SN - 1341-9625

ER -